The role of hematological parameters in differentiating Plasmodium falciparum and others – a study from Somalia
DOI:
https://doi.org/10.15584/ejcem.2022.4.8Keywords:
malaria, Plasmodium falciparum, Plasmodium vivax, plateletsAbstract
Introduction and aim. Accurate identification of Plasmodium species is important because of the differences in their treatment. We aimed to investigate the role of hematological and biochemical parameters in the differentiation of Plasmodium falciparum and other plasmodium species.
Material and methods. This is a retrospective study. Patients admitted to the emergency department with signs and symptoms of malaria were included into the study. Patients with malaria were grouped as P. falciparum and others. Hematological parameters of two groups were compared by univariate and multivariate analysis. Statistical analysis was performed using the Jamovi.
Results. A total of 107 patients were included in the study. According to univariant and multivariant analysis there was no difference in between two groups in the terms of blood urea nitrogen, aspartate aminotransferase, total bilirubin, hemoglobin, hematocrit, white blood cell count, platelet count, and mean platelet volume (in univariate analysis p values were 0.029, 0.011, 0.019, 0.171, 0.870, 0.307, 0.042, and 0.276, respectively and in multivariate analysis p values for blood urea nitrogen, aspartate aminotransferase, total bilirubin, hemoglobin, and platelet count were 0.100, 0.535, 0.328, and 0.213, respectively).
Conclusion. The investigated hematological and biochemical parameters were found to be not valuable in predicting type of malaria. On the other hand, we recommend confirming the results of our study with larger samples and multicenter studies.
Downloads
References
Tabassum A, Iqbal MS, Alghoraiby RA, et al. Hematological profile in smear positive malaria cases: A cross sectional study. Annals of RSCB. 2021;21(4):2297-2309.
Worrall E, Rietveld A, Delacollette C. The burden of malaria epidemics and cost-effectiveness of interventions in epidemic situations in Africa. Am J Trop Med Hyg. 2004;71(2):136-140.
Mathison BA, Pritt BS. Update on Malaria Diagnostics and Test Utilization. J Clin Microbiol. 2017;55(7):2009-2017. doi: 10.1128/JCM.02562-16
Agbana HB, Rogier E, Lo A, et al. Detecting asymptomatic carriage of Plasmodium falciparum in southern Ghana: utility of molecular and serological diagnostic tools. Malar J. 2022;21(1):57. doi: 10.1186/s12936-022-04078-w
Phyo AP, Dahal P, Mayxay M, Ashley EA. Clinical impact of vivax malaria: A collection review. PLoS Med. 2022;19(1):e1003890. doi: 10.1371/journal.pmed.1003890
Awoke N, Arota A. Profiles of hematological parameters in Plasmodium falciparum and Plasmodium vivax malaria patients attending Tercha General Hospital, Dawuro Zone, South Ethiopia. Infect Drug Resist. 2019;12:521-527. doi: 10.2147/IDR.S184489.
Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29-36. doi: 10.1148/radiology.143.1.7063747
Özdemir S, Algın A. Interpretation of the area under the receiver operating characteristic curve. Exp App Med Sci. 2022;3(1):310-311.
Blackman NJ. Systematic reviews of evaluations of diagnostic and screening tests. Odds ratio is not independent of prevalence. BMJ. 2001;323(7322):1188.
Price CP, Newall RG, Boyd JC. Use of protein:creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review. Clin Chem. 2005;51(9):1577-1586. doi: 10.1373/clinchem.2005.049742
Gruell H, Hamacher L, Jennissen V, et al. On Taking a Different Route: An Unlikely Case of Malaria by Nosocomial Transmission. Clin Infect Dis. 2017;65(8):1404-1406. doi: 10.1093/cid/cix520
Önlen Y, Çulha G, Ocak S, Savaş L, Güllü M. Yurtdışı kökenli Plasmodium falciparum sıtması: dört olgu sunumu. Türk Parazitol Derg. 2007;31(4):256-259.
Khan SJ, Abbass Y, Marwat MA. Thrombocytopenia as an indicator of malaria in adult population. Malar Res Treat. 2012;2012:405981. doi: 10.1155/2012/405981
Aitken EH, Alemu A, Rogerson SJ. Neutrophils and Malaria. Front Immunol. 2018;9:3005. doi: 10.3389/fimmu.2018.03005
White NJ. Anaemia and malaria. Malar J. 2018;17(1):371. doi: 10.1186/s12936-018-2509-9
Surve KM, Kulkarni AS, Rathod SG, Bindu RS. Study of haematological parameters in malaria. Int J Res Med Sci. 2017;5(6):2552-2557. doi:10.18203/2320-6012.ijrms20172446
Richards MW, Behrens RH, Doherty JF. Hematologic changes in Acute, Imported Plasmodium falciparum Malaria. Am J Trop Med Hyg. 1998;59(6):859.
Bashawri LAM, Mandil AA, Bahnassy AA, Ahmed MA. Malaria: Haematological Aspects. Annals of Saudi Medicine. 2002;22(5-6):372-377.
Bayleyegn B, Asrie F, Yalew A, Woldu B. Role of platelet indices as a potential marker for malaria severity. J Parasitol Res. 2021;2021:5531091. doi: 10.1155/2021/5531091
Özdemir S, Algın A. The Role of Platelet Indices in Predicting Short-Term Mortality in Elderly Patients with Pulmonary Embolism. J Contemp Med. 2021;11(6):833-837.
Mooney JP, Galloway LJ, Riley EM. Malaria, anemia, and invasive bacterial disease: A neutrophil problem? J Leukoc Biol. 2019;105(4):645-655. doi: 10.1002/JLB.3RI1018-400R
Rodrigues-da-Silva RN, Lima-Junior Jda C, et al. Alterations in cytokines and haematological parameters during the acute and convalescent phases of Plasmodium falciparum and Plasmodium vivax infections. Mem Inst Oswaldo Cruz. 2014;109(2):154-162. doi: 10.1590/0074-0276140275
Arévalo-Herrera M, Lopez-Perez M, Medina L, Moreno A, Gutierrez JB, Herrera S. Clinical profile of Plasmodium falciparum and Plasmodium vivax infections in low and unstable malaria transmission settings of Colombia. Malar J. 2015;14:154. doi: 10.1186/s12936-015-0678-3
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 European Journal of Clinical and Experimental Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.




